AlenCiken

FDA Emergency Use Authorization for use of gammaCore Sapphire™

NASDAQ:ECOR   electroCore, Inc.
electroCore Announces FDA Emergency Use Authorization for use of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients.

investor.electrocore...se-authorization-use

www.marketwatch...e-cv-2020-07-13?siteid=yho...


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.